nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—pituitary gland—breast cancer	0.0125	0.15	CbGeAlD
Pasireotide—SSTR3—pituitary gland—breast cancer	0.012	0.144	CbGeAlD
Pasireotide—SSTR5—endocrine gland—breast cancer	0.00967	0.116	CbGeAlD
Pasireotide—SSTR1—pituitary gland—breast cancer	0.00946	0.114	CbGeAlD
Pasireotide—SSTR3—endocrine gland—breast cancer	0.00927	0.112	CbGeAlD
Pasireotide—SSTR1—female reproductive system—breast cancer	0.00866	0.104	CbGeAlD
Pasireotide—SSTR2—pituitary gland—breast cancer	0.00804	0.0968	CbGeAlD
Pasireotide—SSTR1—endocrine gland—breast cancer	0.00733	0.0882	CbGeAlD
Pasireotide—SSTR2—endocrine gland—breast cancer	0.00623	0.075	CbGeAlD
Pasireotide—Desmopressin—PTGS1—breast cancer	0.000548	0.636	CrCbGaD
Pasireotide—Pruritus—Tamoxifen—breast cancer	0.000506	0.00105	CcSEcCtD
Pasireotide—Myalgia—Fluorouracil—breast cancer	0.000505	0.00105	CcSEcCtD
Pasireotide—Fatigue—Thiotepa—breast cancer	0.000504	0.00105	CcSEcCtD
Pasireotide—Diarrhoea—Vinblastine—breast cancer	0.000504	0.00105	CcSEcCtD
Pasireotide—Asthenia—Melphalan—breast cancer	0.000503	0.00105	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinorelbine—breast cancer	0.000501	0.00104	CcSEcCtD
Pasireotide—Constipation—Thiotepa—breast cancer	0.0005	0.00104	CcSEcCtD
Pasireotide—Pruritus—Melphalan—breast cancer	0.000496	0.00103	CcSEcCtD
Pasireotide—Hypoglycaemia—Epirubicin—breast cancer	0.000491	0.00102	CcSEcCtD
Pasireotide—Asthenia—Goserelin—breast cancer	0.000491	0.00102	CcSEcCtD
Pasireotide—Diarrhoea—Tamoxifen—breast cancer	0.00049	0.00102	CcSEcCtD
Pasireotide—Back pain—Paclitaxel—breast cancer	0.000488	0.00102	CcSEcCtD
Pasireotide—Dizziness—Vinblastine—breast cancer	0.000487	0.00101	CcSEcCtD
Pasireotide—Abdominal pain—Vinorelbine—breast cancer	0.000484	0.00101	CcSEcCtD
Pasireotide—Oedema peripheral—Docetaxel—breast cancer	0.000484	0.00101	CcSEcCtD
Pasireotide—Pruritus—Goserelin—breast cancer	0.000484	0.00101	CcSEcCtD
Pasireotide—Diarrhoea—Melphalan—breast cancer	0.00048	0.000998	CcSEcCtD
Pasireotide—Pain in extremity—Epirubicin—breast cancer	0.000479	0.000997	CcSEcCtD
Pasireotide—Gastrointestinal pain—Thiotepa—breast cancer	0.000478	0.000995	CcSEcCtD
Pasireotide—Nausea—Chlorambucil—breast cancer	0.000478	0.000994	CcSEcCtD
Pasireotide—Dizziness—Tamoxifen—breast cancer	0.000473	0.000985	CcSEcCtD
Pasireotide—Hypotension—Mitoxantrone—breast cancer	0.000472	0.000982	CcSEcCtD
Pasireotide—Hypotension—Irinotecan—breast cancer	0.000472	0.000982	CcSEcCtD
Pasireotide—Oedema peripheral—Capecitabine—breast cancer	0.000469	0.000975	CcSEcCtD
Pasireotide—Vomiting—Vinblastine—breast cancer	0.000469	0.000975	CcSEcCtD
Pasireotide—Diarrhoea—Goserelin—breast cancer	0.000468	0.000973	CcSEcCtD
Pasireotide—Anaemia—Paclitaxel—breast cancer	0.000466	0.000971	CcSEcCtD
Pasireotide—Abdominal pain—Thiotepa—breast cancer	0.000462	0.000962	CcSEcCtD
Pasireotide—Headache—Vinblastine—breast cancer	0.000462	0.000961	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.00046	0.000957	CcSEcCtD
Pasireotide—Hypotension—Gemcitabine—breast cancer	0.00046	0.000957	CcSEcCtD
Pasireotide—Insomnia—Irinotecan—breast cancer	0.000457	0.00095	CcSEcCtD
Pasireotide—Vomiting—Tamoxifen—breast cancer	0.000455	0.000947	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—breast cancer	0.000454	0.000945	CcSEcCtD
Pasireotide—Vertigo—Paclitaxel—breast cancer	0.000453	0.000943	CcSEcCtD
Pasireotide—Dizziness—Goserelin—breast cancer	0.000452	0.000941	CcSEcCtD
Pasireotide—Hypotension—Fluorouracil—breast cancer	0.000452	0.00094	CcSEcCtD
Pasireotide—Headache—Tamoxifen—breast cancer	0.000448	0.000933	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000448	0.000933	CcSEcCtD
Pasireotide—Vomiting—Melphalan—breast cancer	0.000446	0.000927	CcSEcCtD
Pasireotide—Insomnia—Gemcitabine—breast cancer	0.000445	0.000926	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—breast cancer	0.000443	0.000922	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000441	0.000917	CcSEcCtD
Pasireotide—Asthenia—Vinorelbine—breast cancer	0.000439	0.000914	CcSEcCtD
Pasireotide—Dry skin—Epirubicin—breast cancer	0.000439	0.000914	CcSEcCtD
Pasireotide—Decreased appetite—Mitoxantrone—breast cancer	0.000439	0.000914	CcSEcCtD
Pasireotide—Decreased appetite—Irinotecan—breast cancer	0.000439	0.000914	CcSEcCtD
Pasireotide—Nausea—Vinblastine—breast cancer	0.000438	0.000911	CcSEcCtD
Pasireotide—Abdominal pain upper—Epirubicin—breast cancer	0.000438	0.000911	CcSEcCtD
Pasireotide—Insomnia—Fluorouracil—breast cancer	0.000437	0.00091	CcSEcCtD
Pasireotide—Hypokalaemia—Epirubicin—breast cancer	0.000436	0.000907	CcSEcCtD
Pasireotide—Hypertension—Paclitaxel—breast cancer	0.000436	0.000907	CcSEcCtD
Pasireotide—Fatigue—Irinotecan—breast cancer	0.000435	0.000906	CcSEcCtD
Pasireotide—Fatigue—Mitoxantrone—breast cancer	0.000435	0.000906	CcSEcCtD
Pasireotide—Vomiting—Goserelin—breast cancer	0.000435	0.000905	CcSEcCtD
Pasireotide—Alopecia—Docetaxel—breast cancer	0.000434	0.000904	CcSEcCtD
Pasireotide—Pruritus—Vinorelbine—breast cancer	0.000433	0.000901	CcSEcCtD
Pasireotide—Constipation—Irinotecan—breast cancer	0.000432	0.000899	CcSEcCtD
Pasireotide—Constipation—Mitoxantrone—breast cancer	0.000432	0.000899	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000431	0.000898	CcSEcCtD
Pasireotide—Arthralgia—Paclitaxel—breast cancer	0.00043	0.000894	CcSEcCtD
Pasireotide—Myalgia—Paclitaxel—breast cancer	0.00043	0.000894	CcSEcCtD
Pasireotide—Nasopharyngitis—Epirubicin—breast cancer	0.000428	0.000891	CcSEcCtD
Pasireotide—Headache—Goserelin—breast cancer	0.000428	0.000891	CcSEcCtD
Pasireotide—Anxiety—Paclitaxel—breast cancer	0.000428	0.000891	CcSEcCtD
Pasireotide—Decreased appetite—Gemcitabine—breast cancer	0.000428	0.00089	CcSEcCtD
Pasireotide—Nausea—Tamoxifen—breast cancer	0.000425	0.000885	CcSEcCtD
Pasireotide—Fatigue—Gemcitabine—breast cancer	0.000424	0.000883	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000423	0.000879	CcSEcCtD
Pasireotide—Constipation—Gemcitabine—breast cancer	0.000421	0.000875	CcSEcCtD
Pasireotide—Decreased appetite—Fluorouracil—breast cancer	0.00042	0.000875	CcSEcCtD
Pasireotide—Alopecia—Capecitabine—breast cancer	0.00042	0.000875	CcSEcCtD
Pasireotide—Asthenia—Thiotepa—breast cancer	0.00042	0.000873	CcSEcCtD
Pasireotide—Diarrhoea—Vinorelbine—breast cancer	0.000419	0.000872	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—breast cancer	0.000417	0.000867	CcSEcCtD
Pasireotide—Nausea—Melphalan—breast cancer	0.000416	0.000866	CcSEcCtD
Pasireotide—Influenza—Epirubicin—breast cancer	0.000414	0.000862	CcSEcCtD
Pasireotide—Back pain—Docetaxel—breast cancer	0.000414	0.000861	CcSEcCtD
Pasireotide—Pruritus—Thiotepa—breast cancer	0.000414	0.000861	CcSEcCtD
Pasireotide—Gastrointestinal pain—Irinotecan—breast cancer	0.000413	0.000859	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000413	0.000859	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—breast cancer	0.000406	0.000846	CcSEcCtD
Pasireotide—Nausea—Goserelin—breast cancer	0.000406	0.000845	CcSEcCtD
Pasireotide—Dizziness—Vinorelbine—breast cancer	0.000405	0.000843	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—breast cancer	0.000405	0.000842	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—breast cancer	0.000403	0.000839	CcSEcCtD
Pasireotide—Back pain—Capecitabine—breast cancer	0.000401	0.000834	CcSEcCtD
Pasireotide—Diarrhoea—Thiotepa—breast cancer	0.0004	0.000833	CcSEcCtD
Pasireotide—Abdominal pain—Irinotecan—breast cancer	0.000399	0.000831	CcSEcCtD
Pasireotide—Abdominal pain—Mitoxantrone—breast cancer	0.000399	0.000831	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.000399	0.000831	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—breast cancer	0.000396	0.000825	CcSEcCtD
Pasireotide—Anaemia—Docetaxel—breast cancer	0.000395	0.000823	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000391	0.000814	CcSEcCtD
Pasireotide—Vomiting—Vinorelbine—breast cancer	0.000389	0.00081	CcSEcCtD
Pasireotide—Dizziness—Thiotepa—breast cancer	0.000387	0.000805	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—breast cancer	0.000386	0.000803	CcSEcCtD
Pasireotide—Hypotension—Paclitaxel—breast cancer	0.000385	0.000801	CcSEcCtD
Pasireotide—Headache—Vinorelbine—breast cancer	0.000384	0.000798	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—breast cancer	0.000383	0.000797	CcSEcCtD
Pasireotide—Anaemia—Capecitabine—breast cancer	0.000383	0.000797	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000375	0.000781	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—breast cancer	0.000374	0.000777	CcSEcCtD
Pasireotide—Insomnia—Paclitaxel—breast cancer	0.000373	0.000775	CcSEcCtD
Pasireotide—Vertigo—Capecitabine—breast cancer	0.000372	0.000774	CcSEcCtD
Pasireotide—Vomiting—Thiotepa—breast cancer	0.000372	0.000774	CcSEcCtD
Pasireotide—Hypertension—Docetaxel—breast cancer	0.000369	0.000768	CcSEcCtD
Pasireotide—Headache—Thiotepa—breast cancer	0.000366	0.000762	CcSEcCtD
Pasireotide—Myalgia—Docetaxel—breast cancer	0.000364	0.000758	CcSEcCtD
Pasireotide—Arthralgia—Docetaxel—breast cancer	0.000364	0.000758	CcSEcCtD
Pasireotide—Nausea—Vinorelbine—breast cancer	0.000364	0.000757	CcSEcCtD
Pasireotide—Asthenia—Mitoxantrone—breast cancer	0.000362	0.000754	CcSEcCtD
Pasireotide—Asthenia—Irinotecan—breast cancer	0.000362	0.000754	CcSEcCtD
Pasireotide—Decreased appetite—Paclitaxel—breast cancer	0.000358	0.000745	CcSEcCtD
Pasireotide—Hypertension—Capecitabine—breast cancer	0.000358	0.000744	CcSEcCtD
Pasireotide—Fatigue—Paclitaxel—breast cancer	0.000355	0.000739	CcSEcCtD
Pasireotide—Asthenia—Gemcitabine—breast cancer	0.000353	0.000734	CcSEcCtD
Pasireotide—Arthralgia—Capecitabine—breast cancer	0.000353	0.000734	CcSEcCtD
Pasireotide—Myalgia—Capecitabine—breast cancer	0.000353	0.000734	CcSEcCtD
Pasireotide—Constipation—Paclitaxel—breast cancer	0.000352	0.000733	CcSEcCtD
Pasireotide—Anxiety—Capecitabine—breast cancer	0.000351	0.000731	CcSEcCtD
Pasireotide—Pruritus—Gemcitabine—breast cancer	0.000348	0.000724	CcSEcCtD
Pasireotide—Nausea—Thiotepa—breast cancer	0.000347	0.000723	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—breast cancer	0.000346	0.000719	CcSEcCtD
Pasireotide—Diarrhoea—Mitoxantrone—breast cancer	0.000346	0.000719	CcSEcCtD
Pasireotide—Diarrhoea—Irinotecan—breast cancer	0.000346	0.000719	CcSEcCtD
Pasireotide—Pruritus—Fluorouracil—breast cancer	0.000342	0.000712	CcSEcCtD
Pasireotide—Gastrointestinal pain—Paclitaxel—breast cancer	0.000337	0.000701	CcSEcCtD
Pasireotide—Diarrhoea—Gemcitabine—breast cancer	0.000337	0.0007	CcSEcCtD
Pasireotide—Dizziness—Irinotecan—breast cancer	0.000334	0.000695	CcSEcCtD
Pasireotide—Diarrhoea—Fluorouracil—breast cancer	0.000331	0.000689	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—breast cancer	0.000327	0.000679	CcSEcCtD
Pasireotide—Hypotension—Docetaxel—breast cancer	0.000326	0.000679	CcSEcCtD
Pasireotide—Abdominal pain—Paclitaxel—breast cancer	0.000326	0.000678	CcSEcCtD
Pasireotide—Vomiting—Mitoxantrone—breast cancer	0.000321	0.000668	CcSEcCtD
Pasireotide—Vomiting—Irinotecan—breast cancer	0.000321	0.000668	CcSEcCtD
Pasireotide—Dizziness—Fluorouracil—breast cancer	0.00032	0.000666	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000318	0.000662	CcSEcCtD
Pasireotide—Headache—Irinotecan—breast cancer	0.000316	0.000658	CcSEcCtD
Pasireotide—Headache—Mitoxantrone—breast cancer	0.000316	0.000658	CcSEcCtD
Pasireotide—Hypotension—Capecitabine—breast cancer	0.000316	0.000657	CcSEcCtD
Pasireotide—Insomnia—Docetaxel—breast cancer	0.000316	0.000657	CcSEcCtD
Pasireotide—Desmopressin—PTGS2—breast cancer	0.000313	0.364	CrCbGaD
Pasireotide—Alopecia—Methotrexate—breast cancer	0.000313	0.000651	CcSEcCtD
Pasireotide—Vomiting—Gemcitabine—breast cancer	0.000313	0.000651	CcSEcCtD
Pasireotide—Headache—Gemcitabine—breast cancer	0.000308	0.000641	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000308	0.000641	CcSEcCtD
Pasireotide—Vomiting—Fluorouracil—breast cancer	0.000308	0.00064	CcSEcCtD
Pasireotide—Insomnia—Capecitabine—breast cancer	0.000306	0.000636	CcSEcCtD
Pasireotide—Decreased appetite—Docetaxel—breast cancer	0.000303	0.000631	CcSEcCtD
Pasireotide—Headache—Fluorouracil—breast cancer	0.000303	0.000631	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—breast cancer	0.000302	0.000629	CcSEcCtD
Pasireotide—Fatigue—Docetaxel—breast cancer	0.000301	0.000626	CcSEcCtD
Pasireotide—Nausea—Mitoxantrone—breast cancer	0.0003	0.000624	CcSEcCtD
Pasireotide—Nausea—Irinotecan—breast cancer	0.0003	0.000624	CcSEcCtD
Pasireotide—Constipation—Docetaxel—breast cancer	0.000299	0.000621	CcSEcCtD
Pasireotide—Back pain—Methotrexate—breast cancer	0.000298	0.000621	CcSEcCtD
Pasireotide—Asthenia—Paclitaxel—breast cancer	0.000296	0.000615	CcSEcCtD
Pasireotide—Decreased appetite—Capecitabine—breast cancer	0.000294	0.000611	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—breast cancer	0.000293	0.000609	CcSEcCtD
Pasireotide—Nausea—Gemcitabine—breast cancer	0.000292	0.000608	CcSEcCtD
Pasireotide—Fatigue—Capecitabine—breast cancer	0.000291	0.000606	CcSEcCtD
Pasireotide—Pruritus—Paclitaxel—breast cancer	0.000291	0.000606	CcSEcCtD
Pasireotide—Constipation—Capecitabine—breast cancer	0.000289	0.000601	CcSEcCtD
Pasireotide—Nausea—Fluorouracil—breast cancer	0.000287	0.000598	CcSEcCtD
Pasireotide—Gastrointestinal pain—Docetaxel—breast cancer	0.000285	0.000594	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—breast cancer	0.000285	0.000593	CcSEcCtD
Pasireotide—Diarrhoea—Paclitaxel—breast cancer	0.000282	0.000586	CcSEcCtD
Pasireotide—Back pain—Epirubicin—breast cancer	0.000279	0.000581	CcSEcCtD
Pasireotide—Vertigo—Methotrexate—breast cancer	0.000277	0.000576	CcSEcCtD
Pasireotide—Gastrointestinal pain—Capecitabine—breast cancer	0.000276	0.000575	CcSEcCtD
Pasireotide—Abdominal pain—Docetaxel—breast cancer	0.000276	0.000574	CcSEcCtD
Pasireotide—Dizziness—Paclitaxel—breast cancer	0.000272	0.000567	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—breast cancer	0.000271	0.000564	CcSEcCtD
Pasireotide—Abdominal pain—Capecitabine—breast cancer	0.000267	0.000556	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—breast cancer	0.000267	0.000555	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—breast cancer	0.000262	0.000546	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—breast cancer	0.000262	0.000546	CcSEcCtD
Pasireotide—Vomiting—Paclitaxel—breast cancer	0.000262	0.000545	CcSEcCtD
Pasireotide—Vertigo—Epirubicin—breast cancer	0.000259	0.000539	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—breast cancer	0.000258	0.000537	CcSEcCtD
Pasireotide—Headache—Paclitaxel—breast cancer	0.000258	0.000537	CcSEcCtD
Pasireotide—Asthenia—Docetaxel—breast cancer	0.00025	0.000521	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—breast cancer	0.000249	0.000518	CcSEcCtD
Pasireotide—Pruritus—Docetaxel—breast cancer	0.000247	0.000514	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—breast cancer	0.000247	0.000513	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—breast cancer	0.000246	0.000511	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—breast cancer	0.000246	0.000511	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—breast cancer	0.000245	0.000509	CcSEcCtD
Pasireotide—Nausea—Paclitaxel—breast cancer	0.000245	0.000509	CcSEcCtD
Pasireotide—Asthenia—Capecitabine—breast cancer	0.000243	0.000505	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—breast cancer	0.00024	0.000499	CcSEcCtD
Pasireotide—Pruritus—Capecitabine—breast cancer	0.000239	0.000498	CcSEcCtD
Pasireotide—Diarrhoea—Docetaxel—breast cancer	0.000239	0.000497	CcSEcCtD
Pasireotide—Hypotension—Methotrexate—breast cancer	0.000235	0.000489	CcSEcCtD
Pasireotide—Diarrhoea—Capecitabine—breast cancer	0.000231	0.000481	CcSEcCtD
Pasireotide—Dizziness—Docetaxel—breast cancer	0.000231	0.00048	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—breast cancer	0.00023	0.00048	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000229	0.000477	CcSEcCtD
Pasireotide—Insomnia—Methotrexate—breast cancer	0.000228	0.000474	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—breast cancer	0.000227	0.000473	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—breast cancer	0.000227	0.000473	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—breast cancer	0.000227	0.000471	CcSEcCtD
Pasireotide—Dizziness—Capecitabine—breast cancer	0.000224	0.000465	CcSEcCtD
Pasireotide—Vomiting—Docetaxel—breast cancer	0.000222	0.000462	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—breast cancer	0.00022	0.000458	CcSEcCtD
Pasireotide—Decreased appetite—Methotrexate—breast cancer	0.000219	0.000455	CcSEcCtD
Pasireotide—Headache—Docetaxel—breast cancer	0.000219	0.000455	CcSEcCtD
Pasireotide—Fatigue—Methotrexate—breast cancer	0.000217	0.000451	CcSEcCtD
Pasireotide—Vomiting—Capecitabine—breast cancer	0.000215	0.000447	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000215	0.000446	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—breast cancer	0.000213	0.000443	CcSEcCtD
Pasireotide—Headache—Capecitabine—breast cancer	0.000212	0.000441	CcSEcCtD
Pasireotide—Nausea—Docetaxel—breast cancer	0.000207	0.000431	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—breast cancer	0.000206	0.000428	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—breast cancer	0.000205	0.000426	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—breast cancer	0.000204	0.000424	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—breast cancer	0.000203	0.000422	CcSEcCtD
Pasireotide—Constipation—Epirubicin—breast cancer	0.000201	0.000419	CcSEcCtD
Pasireotide—Nausea—Capecitabine—breast cancer	0.000201	0.000418	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—breast cancer	0.000199	0.000414	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000199	0.000413	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—breast cancer	0.000197	0.00041	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—breast cancer	0.000193	0.000401	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—breast cancer	0.000189	0.000394	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—breast cancer	0.000188	0.000391	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—breast cancer	0.000186	0.000388	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—breast cancer	0.000186	0.000387	CcSEcCtD
Pasireotide—Asthenia—Methotrexate—breast cancer	0.000181	0.000376	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—breast cancer	0.000178	0.000371	CcSEcCtD
Pasireotide—Pruritus—Methotrexate—breast cancer	0.000178	0.00037	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—breast cancer	0.000172	0.000358	CcSEcCtD
Pasireotide—Diarrhoea—Methotrexate—breast cancer	0.000172	0.000358	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—breast cancer	0.000169	0.000352	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—breast cancer	0.000167	0.000347	CcSEcCtD
Pasireotide—Dizziness—Methotrexate—breast cancer	0.000166	0.000346	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—breast cancer	0.000161	0.000335	CcSEcCtD
Pasireotide—Vomiting—Methotrexate—breast cancer	0.00016	0.000333	CcSEcCtD
Pasireotide—Headache—Methotrexate—breast cancer	0.000158	0.000328	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—breast cancer	0.000156	0.000325	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—breast cancer	0.000156	0.000324	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—breast cancer	0.000154	0.000321	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—breast cancer	0.00015	0.000312	CcSEcCtD
Pasireotide—Nausea—Methotrexate—breast cancer	0.000149	0.000311	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—breast cancer	0.000149	0.00031	CcSEcCtD
Pasireotide—Headache—Epirubicin—breast cancer	0.000148	0.000307	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—breast cancer	0.000144	0.0003	CcSEcCtD
Pasireotide—Nausea—Epirubicin—breast cancer	0.00014	0.000291	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—breast cancer	0.000139	0.000288	CcSEcCtD
Pasireotide—Headache—Doxorubicin—breast cancer	0.000136	0.000284	CcSEcCtD
Pasireotide—Nausea—Doxorubicin—breast cancer	0.000129	0.000269	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—IGF1R—breast cancer	7.88e-05	0.000181	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—breast cancer	7.84e-05	0.00018	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPP1—breast cancer	7.75e-05	0.000178	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—breast cancer	7.74e-05	0.000178	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LEP—breast cancer	7.73e-05	0.000178	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—breast cancer	7.72e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ESR1—breast cancer	7.7e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NCOR1—breast cancer	7.69e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PLA2G4A—breast cancer	7.69e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB3—breast cancer	7.66e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CAV1—breast cancer	7.66e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGFR2—breast cancer	7.65e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FN1—breast cancer	7.61e-05	0.000175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF1—breast cancer	7.61e-05	0.000175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CSF2—breast cancer	7.61e-05	0.000175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RAF1—breast cancer	7.59e-05	0.000174	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—breast cancer	7.58e-05	0.000174	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NRG1—breast cancer	7.55e-05	0.000173	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKBIA—breast cancer	7.52e-05	0.000173	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—H2AFX—breast cancer	7.5e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—breast cancer	7.49e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH1—breast cancer	7.44e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—E2F1—breast cancer	7.44e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—breast cancer	7.41e-05	0.00017	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ESR1—breast cancer	7.38e-05	0.00017	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—breast cancer	7.37e-05	0.000169	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—breast cancer	7.35e-05	0.000169	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FN1—breast cancer	7.29e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—breast cancer	7.28e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—breast cancer	7.28e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—breast cancer	7.28e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKBIA—breast cancer	7.21e-05	0.000165	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGF—breast cancer	7.2e-05	0.000165	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPP1—breast cancer	7.15e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH1—breast cancer	7.14e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGFR1—breast cancer	7.13e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—breast cancer	7.12e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB3—breast cancer	7.07e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGFR2—breast cancer	7.06e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIF1A—breast cancer	7.03e-05	0.000161	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—breast cancer	6.98e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—breast cancer	6.98e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIT—breast cancer	6.98e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK3—breast cancer	6.97e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGF—breast cancer	6.9e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LEP—breast cancer	6.86e-05	0.000157	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—breast cancer	6.84e-05	0.000157	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—breast cancer	6.8e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CAV1—breast cancer	6.8e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—breast cancer	6.78e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—breast cancer	6.72e-05	0.000154	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK3—breast cancer	6.68e-05	0.000153	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1—breast cancer	6.66e-05	0.000153	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT2—breast cancer	6.66e-05	0.000153	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—breast cancer	6.63e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGFR1—breast cancer	6.58e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—breast cancer	6.56e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ESR1—breast cancer	6.55e-05	0.00015	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIF1A—breast cancer	6.48e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FN1—breast cancer	6.47e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—breast cancer	6.4e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKBIA—breast cancer	6.39e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1—breast cancer	6.39e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT2—breast cancer	6.39e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—breast cancer	6.36e-05	0.000146	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—breast cancer	6.34e-05	0.000146	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SERPINE1—breast cancer	6.33e-05	0.000145	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH1—breast cancer	6.33e-05	0.000145	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LEP—breast cancer	6.33e-05	0.000145	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CAV1—breast cancer	6.27e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—breast cancer	6.27e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—breast cancer	6.2e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—breast cancer	6.19e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—breast cancer	6.19e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—breast cancer	6.19e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—breast cancer	6.14e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGF—breast cancer	6.12e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—breast cancer	6.08e-05	0.00014	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SERPINE1—breast cancer	6.07e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ESR1—breast cancer	6.04e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOS3—breast cancer	6.04e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—breast cancer	6.01e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FN1—breast cancer	5.97e-05	0.000137	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK3—breast cancer	5.93e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKBIA—breast cancer	5.9e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH1—breast cancer	5.84e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—breast cancer	5.82e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOS3—breast cancer	5.79e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—breast cancer	5.76e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MDM2—breast cancer	5.73e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAF1—breast cancer	5.71e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—breast cancer	5.71e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—breast cancer	5.71e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—breast cancer	5.71e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RELA—breast cancer	5.69e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1—breast cancer	5.67e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT2—breast cancer	5.66e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB2—breast cancer	5.65e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGF—breast cancer	5.65e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—breast cancer	5.64e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—breast cancer	5.58e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—breast cancer	5.58e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—breast cancer	5.52e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MDM2—breast cancer	5.5e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAF1—breast cancer	5.48e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK3—breast cancer	5.47e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RELA—breast cancer	5.45e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—breast cancer	5.44e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB2—breast cancer	5.42e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—breast cancer	5.39e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SERPINE1—breast cancer	5.38e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—breast cancer	5.37e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—breast cancer	5.36e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—breast cancer	5.35e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—breast cancer	5.35e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—breast cancer	5.33e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—breast cancer	5.33e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—breast cancer	5.23e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1—breast cancer	5.23e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT2—breast cancer	5.23e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—breast cancer	5.2e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—breast cancer	5.18e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—breast cancer	5.14e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOS3—breast cancer	5.14e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—breast cancer	5.13e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—breast cancer	5.12e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—breast cancer	5.11e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—breast cancer	5.1e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—breast cancer	5.02e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—breast cancer	5.02e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—breast cancer	4.99e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—breast cancer	4.98e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—breast cancer	4.97e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SERPINE1—breast cancer	4.97e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—breast cancer	4.96e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—breast cancer	4.95e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—breast cancer	4.92e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—breast cancer	4.92e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—breast cancer	4.91e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—breast cancer	4.89e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—breast cancer	4.89e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MDM2—breast cancer	4.87e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAF1—breast cancer	4.86e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—breast cancer	4.85e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RELA—breast cancer	4.84e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—breast cancer	4.83e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—breast cancer	4.82e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB2—breast cancer	4.81e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—breast cancer	4.79e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—breast cancer	4.78e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—breast cancer	4.74e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—breast cancer	4.74e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOS3—breast cancer	4.74e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—breast cancer	4.74e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK8—breast cancer	4.72e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—breast cancer	4.7e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—breast cancer	4.65e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—breast cancer	4.63e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—breast cancer	4.62e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—breast cancer	4.56e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—breast cancer	4.53e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK8—breast cancer	4.52e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—breast cancer	4.52e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—breast cancer	4.51e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MDM2—breast cancer	4.5e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAF1—breast cancer	4.48e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SRC—breast cancer	4.47e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RELA—breast cancer	4.46e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—breast cancer	4.45e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB2—breast cancer	4.44e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—breast cancer	4.4e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—breast cancer	4.38e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—breast cancer	4.38e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—breast cancer	4.36e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—breast cancer	4.36e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—breast cancer	4.35e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—breast cancer	4.33e-05	9.95e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—breast cancer	4.31e-05	9.9e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SRC—breast cancer	4.29e-05	9.84e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—breast cancer	4.25e-05	9.75e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—breast cancer	4.24e-05	9.73e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—breast cancer	4.21e-05	9.66e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—breast cancer	4.2e-05	9.66e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—breast cancer	4.18e-05	9.6e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—breast cancer	4.17e-05	9.59e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—breast cancer	4.13e-05	9.49e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—breast cancer	4.12e-05	9.47e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK3—breast cancer	4.12e-05	9.46e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—breast cancer	4.11e-05	9.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—breast cancer	4.11e-05	9.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—breast cancer	4.1e-05	9.41e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—breast cancer	4.06e-05	9.33e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—breast cancer	4.03e-05	9.25e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—breast cancer	4.02e-05	9.23e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK8—breast cancer	4.01e-05	9.21e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—breast cancer	4.01e-05	9.2e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—breast cancer	4e-05	9.18e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—breast cancer	4e-05	9.18e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—breast cancer	4e-05	9.18e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK3—breast cancer	3.95e-05	9.07e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—breast cancer	3.92e-05	9e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—breast cancer	3.92e-05	9e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—breast cancer	3.91e-05	8.98e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—breast cancer	3.88e-05	8.91e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—breast cancer	3.84e-05	8.82e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—breast cancer	3.83e-05	8.8e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—breast cancer	3.8e-05	8.74e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SRC—breast cancer	3.8e-05	8.73e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—breast cancer	3.79e-05	8.71e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—breast cancer	3.78e-05	8.69e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—breast cancer	3.76e-05	8.63e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—breast cancer	3.7e-05	8.5e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—breast cancer	3.7e-05	8.5e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK8—breast cancer	3.7e-05	8.5e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—breast cancer	3.69e-05	8.47e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—breast cancer	3.67e-05	8.42e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—breast cancer	3.55e-05	8.15e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SRC—breast cancer	3.51e-05	8.05e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK3—breast cancer	3.5e-05	8.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—breast cancer	3.42e-05	7.85e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—breast cancer	3.41e-05	7.82e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—breast cancer	3.4e-05	7.81e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—breast cancer	3.4e-05	7.8e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—breast cancer	3.38e-05	7.77e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—breast cancer	3.33e-05	7.65e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—breast cancer	3.29e-05	7.55e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—breast cancer	3.26e-05	7.49e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK3—breast cancer	3.23e-05	7.42e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—breast cancer	3.15e-05	7.24e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—breast cancer	3.15e-05	7.23e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—breast cancer	3.15e-05	7.22e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—breast cancer	3.14e-05	7.22e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—breast cancer	3.14e-05	7.2e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—breast cancer	3.07e-05	7.06e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—breast cancer	3.02e-05	6.93e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—breast cancer	3.01e-05	6.91e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—breast cancer	2.9e-05	6.67e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—breast cancer	2.89e-05	6.64e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—breast cancer	2.89e-05	6.63e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—breast cancer	2.8e-05	6.42e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—breast cancer	2.78e-05	6.38e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—breast cancer	2.67e-05	6.14e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—breast cancer	2.67e-05	6.13e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—breast cancer	2.66e-05	6.12e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—breast cancer	2.58e-05	5.93e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—breast cancer	2.56e-05	5.88e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—breast cancer	2.47e-05	5.67e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—breast cancer	2.36e-05	5.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—breast cancer	2.36e-05	5.42e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—breast cancer	2.18e-05	5.01e-05	CbGpPWpGaD
